Chinese god group terminates non-public offering

China God Group (000790) announced that the Non-public offering of shares in the condition of complete uncertainty, and ultimately obtain the relevant authorities to approve or approve the time there is uncertainty, the company decided to terminate the non-public issue of stock plans.　　According to previous plans, the company intends to the domestic specific object of the number of non-public offerings not more than 32 million shares, for the Chinese god Group Pharmaceutical plant technical renovation and expansion and new drug research and development projects, Huasheng biotechnology extension and Licatin in-depth research projects, bio-technical transformation of Animal biotechnology extension project and 37 planting base construction and reserve projects.　　The company undertakes not to plan major assets reorganization matters within three months after the announcement. In order to speed up the project construction and development progress, the company will use its own funds to invest in the construction of China-God high-tech industrial Park two (biological agent workshop engineering and Chinese God Group Pharmaceutical Factory). China God high-tech Industrial Park Biological preparation workshop project investment total of 64.5938 million yuan, dynamic investment recovery period of 8.36 years, is expected to be completed in September 2011 acceptance, December 2011 Commissioning. Hua Shen Hi-Tech Industrial Park pharmaceutical Project Investment total of 114.3957 million yuan, dynamic investment recovery period of 8.52 years, is expected to be completed in September 2012 acceptance, December 2012 commissioning. (Gu Xin)